Literature DB >> 20967826

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Wing-Kin Syn1, Steve S Choi, Evaggelia Liaskou, Gamze F Karaca, Kolade M Agboola, Ye Htun Oo, Zhiyong Mi, Thiago A Pereira, Marzena Zdanowicz, Padmini Malladi, Yuping Chen, Cynthia Moylan, Youngmi Jung, Syamal D Bhattacharya, Vanessa Teaberry, Alessia Omenetti, Manal F Abdelmalek, Cynthia D Guy, David H Adams, Paul C Kuo, Gregory A Michelotti, Peter F Whitington, Anna Mae Diehl.   

Abstract

UNLABELLED: Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis. Recently, we showed that NASH-related cirrhosis is associated with Hedgehog (Hh) pathway activation. The gene encoding osteopontin (OPN), a profibrogenic extracellular matrix protein and cytokine, is a direct transcriptional target of the Hh pathway. Thus, we hypothesize that Hh signaling induces OPN to promote liver fibrosis in NASH. Hepatic OPN expression and liver fibrosis were analyzed in wild-type (WT) mice, Patched-deficient (Ptc(+/-) ) (overly active Hh signaling) mice, and OPN-deficient mice before and after feeding methionine and choline-deficient (MCD) diets to induce NASH-related fibrosis. Hepatic OPN was also quantified in human NASH and nondiseased livers. Hh signaling was manipulated in cultured liver cells to assess direct effects on OPN expression, and hepatic stellate cells (HSCs) were cultured in medium with different OPN activities to determine effects on HSC phenotype. When fed MCD diets, Ptc(+/-) mice expressed more OPN and developed worse liver fibrosis (P < 0.05) than WT mice, whereas OPN-deficient mice exhibited reduced fibrosis (P < 0.05). In NASH patients, OPN was significantly up-regulated and correlated with Hh pathway activity and fibrosis stage. During NASH, ductular cells strongly expressed OPN. In cultured HSCs, SAG (an Hh agonist) up-regulated, whereas cyclopamine (an Hh antagonist) repressed OPN expression (P < 0.005). Cholangiocyte-derived OPN and recombinant OPN promoted fibrogenic responses in HSCs (P < 0.05); neutralizing OPN with RNA aptamers attenuated this (P < 0.05).
CONCLUSION: OPN is Hh-regulated and directly promotes profibrogenic responses. OPN induction correlates with Hh pathway activity and fibrosis stage. Therefore, OPN inhibition may be beneficial in NASH.
Copyright © 2010 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967826      PMCID: PMC3025083          DOI: 10.1002/hep.23998

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.

Authors:  Peter Fickert; Andrea Thueringer; Tarek Moustafa; Dagmar Silbert; Judith Gumhold; Oleksiy Tsybrovskyy; Margitta Lebofsky; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Lab Invest       Date:  2010-04-05       Impact factor: 5.662

3.  Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects.

Authors:  Wenbao Huang; Guoxian Zhu; Meixian Huang; Guoqiang Lou; Yi Liu; Shuying Wang
Journal:  Clin Chim Acta       Date:  2010-02-02       Impact factor: 3.786

4.  RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Authors:  Zhiyong Mi; Hongtao Guo; M Benjamin Russell; Yingmiao Liu; Bruce A Sullenger; Paul C Kuo
Journal:  Mol Ther       Date:  2008-11-04       Impact factor: 11.454

5.  Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms.

Authors:  Junko Morimoto; Manabu Inobe; Chiemi Kimura; Shigeyuki Kon; Hongyan Diao; Momoe Aoki; Tadaaki Miyazaki; David T Denhardt; Susan Rittling; Toshimitsu Uede
Journal:  Int Immunol       Date:  2004-03       Impact factor: 4.823

Review 6.  The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer.

Authors:  Alessia Omenetti; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-24       Impact factor: 4.052

7.  Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.

Authors:  Rafal P Witek; Liu Yang; Renshui Liu; Youngmi Jung; Alessia Omenetti; Wing-Kin Syn; Steve S Choi; Yeiwon Cheong; Caitlin M Fearing; Kolade M Agboola; Wei Chen; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

8.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

9.  The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin.

Authors:  Shamik Das; Lillianne G Harris; Brandon J Metge; Suhu Liu; Adam I Riker; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

10.  Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring.

Authors:  Ryoichi Mori; Tanya J Shaw; Paul Martin
Journal:  J Exp Med       Date:  2008-01-07       Impact factor: 14.307

View more
  115 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Authors:  Raquel Urtasun; Aritz Lopategi; Joseph George; Tung-Ming Leung; Yongke Lu; Xiaodong Wang; Xiaodong Ge; Maria Isabel Fiel; Natalia Nieto
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

3.  A hedgehog survival pathway in 'undead' lipotoxic hepatocytes.

Authors:  Keisuke Kakisaka; Sophie C Cazanave; Nathan W Werneburg; Nataliya Razumilava; Joachim C Mertens; Steve F Bronk; Gregory J Gores
Journal:  J Hepatol       Date:  2012-05-26       Impact factor: 25.083

4.  Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease.

Authors:  Hyunjoo Kwon; Kyoungsub Song; Chang Han; Weina Chen; Ying Wang; Srikanta Dash; Kyu Lim; Tong Wu
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

5.  Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy.

Authors:  M Swiderska-Syn; W K Syn; G Xie; L Krüger; M V Machado; G Karaca; G A Michelotti; S S Choi; R T Premont; A M Diehl
Journal:  Gut       Date:  2013-10-30       Impact factor: 23.059

Review 6.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

Review 7.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

Review 8.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

9.  Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.

Authors:  Steve S Choi; Lee C Claridge; Ravi Jhaveri; Marzena Swiderska-Syn; Paul Clark; Ayako Suzuki; Thiago A Pereira; Zhiyong Mi; Paul C Kuo; Cynthia D Guy; Fausto E L Pereira; Anna Mae Diehl; Keyur Patel; Wing-Kin Syn
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

Review 10.  Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.

Authors:  Benjamin D Humphreys
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.